August 22, 2024<\/p>\n<\/p>\n
CollPlant Biotechnologies and Stratasys Ltd. have embarked on a pre-clinical study focused on advancing the development of 200cc regenerative breast implants. Created using CollPlant\u2019s rhCollagen-based bioinks and the Stratasys Origin 3D printer, the study aims to evaluate their potential in promoting natural breast tissue growth while biodegrading over time.<\/p>\n<\/p>\n
This partnership between CollPlant and Stratasys is centered on creating a scalable bioprinting process for the production of regenerative breast implants. Engineered to regenerate natural breast tissue without eliciting an immune reaction, these implants present a viable alternative to traditional silicone implants used in both reconstructive and cosmetic breast surgeries. The current market for breast implants stands at $3 billion, underscoring the considerable impact this innovation could have.<\/p>\n<\/p>\n
Dr. Yoav Zeif, CEO of Stratasys, highlighted the significance of their joint efforts, stating, \u201cThis pre-clinical study signifies a major advancement in our mission to provide patient care through regenerative medicine rather than conventional implants. The work being done by CollPlant is truly groundbreaking, and our partnership demonstrates how Stratasys is dedicated to accelerating innovative timelines and expanding the limits of what’s possible.\u201d<\/p>\n<\/p>\n
Yehiel Tal, the CEO of CollPlant, highlighted his enthusiasm about the advances in their collaborative effort, stating, \u201cWe are extremely happy about the progress we\u2019ve made with our breast implants program, and with Stratasys\u2019 successful achievement to develop a printer that enables us to print a commercial-size implant with high resolution and optimal physical properties.\u201d<\/p>\n<\/p>\n
Expected to release preliminary findings by the first half of 2025, the ongoing pre-clinical study builds on encouraging earlier results that displayed the implants\u2019 capabilities in tissue regeneration, neovascularization, and a strong safety profile. This groundbreaking method could significantly enhance the outcomes of patients beyond traditional breast augmentation techniques like silicone implants or autologous fat transfer.<\/p>\n<\/p>\n
The collaboration between CollPlant and Stratasys in regenerative medicine and 3D printing technology is setting the stage to potentially revolutionize the breast implant industry. The outcome of their study will be key in assessing the feasibility of these implants as a superior and safer choice for individuals seeking reconstructive or cosmetic enhancements.<\/p>\n<\/p>\n
With their joint venture, CollPlant and Stratasys represent the innovation possible when merging regenerative medicine with sophisticated 3D printing technology. By overcoming the limitations of conventional breast implants and pioneering new advancements, both companies are aiming to significantly influence patient care and the wider medical field.<\/p>\n<\/p>\n
Innovative Space Carrier Inc (ISC), headquartered in Japan, has established a strategic collaboration with WAAM3D, Cranfield University, and Aichi Sangyo to push forward the… read more \u00bb<\/p>\n
Envision a scenario where virtual realities are not just visually immersive but also tactile. The field of 3D printing is increasingly facilitating this by merging the… read more \u00bb<\/p>\n
Lamborghini continues to redefine the frontiers of automotive technology with the launch of its new super sports car, the Temerario. Revealed at… read more \u00bb<\/p>\n
This tutorial provides a step-by-step method for designing and putting together a custom stand and air amplifier. This setup lets you experience the benefits of a Noctua desk fan at a significantly reduced cost.<\/p>\n<\/p>\n
3D printing has rapidly become an essential tool in modern engineering, enabling the development of prototypes, components, and fully functional products. This technology… read more \u00bb<\/p>\n<\/p>\n
Researchers from RMIT University in Australia, in collaboration with Tescan Group in Czechia and the University of North Texas in the USA, have… read more \u00bb<\/p>\n<\/p>\n
Discover how maker Fraens 3D printed an easy-to-use table loom, perfect for DIY enthusiasts and weaving newcomers.<\/p>\n<\/p>\n
Drone logistics company Blueflite is set to embark on a new project to develop hydrogen storage tanks for unmanned aerial vehicles (UAVs). This… read more \u00bb<\/p>\n<\/p>\n
Hyliion has been awarded a Small Business Innovation Research (SBIR) government contract by the United States Navy. This contract marks the beginning of… read more \u00bb<\/p>\n
6K Additive has been chosen by the RTX Technology Research Center (RTRC) and the University of Arizona to participate in the Environmental Additive… read more \u00bb<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"
August 22, 2024 CollPlant Biotechnologies and Stratasys Ltd. have embarked on a pre-clinical study focused on advancing the development of 200cc regenerative breast implants. Created using CollPlant\u2019s rhCollagen-based bioinks and the Stratasys Origin 3D printer, the study aims to evaluate their potential in promoting natural breast tissue growth while biodegrading over time. This partnership between […]<\/p>\n","protected":false},"author":0,"featured_media":142,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,5],"tags":[],"class_list":["post-141","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical","category-news"],"yoast_head":"\n